Characterisation of resistance mechanisms developed by basal cell carcinoma cells in response to repeated cycles of Photodynamic Therapy
Author:
Funder
Universidad Autónoma de Madrid
Ministerio de Economía y Competitividad
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-019-41313-y.pdf
Reference84 articles.
1. Qadir, M. I. Skin cancer: Etiology and management. Pak. J. Pharm. Sci. 29, 999–1003 (2016).
2. Aguayo-Leiva, I. R., Ríos-Buceta, L. & Jaén-Olasolo, P. Surgical vs nonsurgical treatment of basal cell carcinoma. Actas Dermosifiliogr. 101, 683–692 (2010).
3. Jaju, P. D., Ransohoff, K. J., Tang, J. Y. & Sarin, K. Y. Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors. J. Am. Acad. Dermatol. 74, 437–451 (2016).
4. Shanley, S. & McCormack, C. Diagnosis and management of hereditary basal cell skin cancer. Recent Results Cancer Res. 205, 191–212 (2016).
5. Bonilla, X. et al. B.8,9,10, Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma. Nat Genet. 48, 398–406 (2016).
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparative response to PDT with methyl-aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cells;Scientific Reports;2024-03-25
2. Antioxidant Enzymes in Cancer Cells: Their Role in Photodynamic Therapy Resistance and Potential as Targets for Improved Treatment Outcomes;International Journal of Molecular Sciences;2024-03-09
3. Treatment of nonmelanoma skin cancer with pro‐differentiation agents and photodynamic therapy: Preclinical and clinical studies (Review);Photochemistry and Photobiology;2024-02-04
4. PTCH1 gene variants rs357564, rs2236405, rs2297086 and rs41313327, mRNA and tissue expression in basal cell carcinoma patients from Western Mexico;Journal of Clinical Laboratory Analysis;2024-01-29
5. The m-TORC1 inhibitor Sirolimus increases the effectiveness of Photodynamic therapy in the treatment of cutaneous Squamous Cell Carcinoma, impairing NRF2 antioxidant signaling;International Journal of Biological Sciences;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3